Skip to main content
An official website of the United States government

p53 peptide vaccine

A peptide-based cancer vaccine composed of amino acids 264 to 272 of the wild-type protein encoded by the P53 gene. p53 peptide vaccine may elicit an HLA-A2.1-restricted cytotoxic T lymphocyte immune response against tumor cells that overexpress p53 protein.
Synonym:p53:264-272 peptide
Code name:MPS-128
PR-147
NSC code:717111
Search NCI's Drug Dictionary